Xerox cut its 2026 adjusted operating income and free cash flow forecasts after Q3 revenue fell 4.7%, despite a wider ...

Wabash National posted a Q3 2026 loss despite higher revenue, as backlog reached $1.3 billion by mid-October and management ...

Wesco raised its 2026 outlook after Q3 sales rose 17% to a record $7.23 billion, supported by broad-based growth and strong ...

West Pharmaceutical Services posted 11.9% organic sales growth and a 35.7% increase in adjusted EPS for Q3 2026, led by ...

Eli Lilly raised its 2026 revenue forecast after Q3 sales rose 39%, driven by Mounjaro, Zepbound and broader incretin volume ...

Antero Midstream’s Q3 2026 adjusted EBITDA rose 3% as gathering volumes increased 19%, while management outlined growth ...

Stagwell Q3 2026 earnings call: revenue rose 10% to $816 million, adjusted EBITDA increased 25%, and management raised its ...

LENZ Therapeutics’ Q3 2026 earnings call covered $2.6 million in product revenue, 51% prescription growth, telehealth ...

NewtekOne reiterated 2026 EPS guidance as Q3 deposits more than doubled year over year and net interest income rose 30%, ...

Pediatrix Medical Group's Q3 2026 earnings call covered $85 million in adjusted EBITDA, 0.6% same-unit growth and a $290 ...

Brunswick Q3 2026 earnings call: sales rose 7%, adjusted EPS gained 63% to $1.58, margins expanded, and full-year EPS ...

Nexa Resources’ 3Q26 net revenue rose 23% year over year to US$937 million, while Adjusted EBITDA increased 62% to US$301 ...